Peyrat JP - Search Results

1

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.

Hebbar M, Révillion F, Louchez MM, Vilain MO, Fournier C, Bonneterre J, Peyrat JP. Hebbar M, et al. Among authors: peyrat jp. Clin Cancer Res. 1998 Feb;4(2):373-80. Clin Cancer Res. 1998. PMID: 9516925

2

Type 1 IGF receptor in human breast diseases.

Peyrat JP, Bonneterre J. Peyrat JP, et al. Breast Cancer Res Treat. 1992;22(1):59-67. doi: 10.1007/BF01833334. Breast Cancer Res Treat. 1992. PMID: 1421425 Review.

3

Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.

Bonneterre J, Peyrat JP, Beuscart R, Demaille A. Bonneterre J, et al. Among authors: peyrat jp. Cancer Res. 1990 Nov 1;50(21):6931-5. Cancer Res. 1990. PMID: 2170011

4

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer.

Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A. Peyrat JP, et al. Eur J Cancer. 1993;29A(4):492-7. doi: 10.1016/s0959-8049(05)80137-6. Eur J Cancer. 1993. PMID: 8435198

5

Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patients.

Revillion F, Hebbar M, Bonneterre J, Peyrat JP. Revillion F, et al. Among authors: peyrat jp. Eur J Cancer. 1996 Feb;32A(2):231-4. doi: 10.1016/0959-8049(95)00568-4. Eur J Cancer. 1996. PMID: 8664033

6

Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.

Peyrat JP, Vanlemmens L, Fournier J, Huet G, Révillion F, Bonneterre J. Peyrat JP, et al. Clin Cancer Res. 1998 Jan;4(1):189-96. Clin Cancer Res. 1998. PMID: 9516970

7

Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy.

Peyrat JP, Révillion F, Bonneterre J. Peyrat JP, et al. Br J Cancer. 1998 May;77(10):1669-71. doi: 10.1038/bjc.1998.274. Br J Cancer. 1998. PMID: 9635846 Free PMC article.

8

Age as a prognostic factor in breast cancer.

Vanlemmens L, Hebbar M, Peyrat JP, Bonneterre J. Vanlemmens L, et al. Among authors: peyrat jp. Anticancer Res. 1998 May-Jun;18(3B):1891-6. Anticancer Res. 1998. PMID: 9677440

9

ERBB2 oncogene in human breast cancer and its clinical significance.

Révillion F, Bonneterre J, Peyrat JP. Révillion F, et al. Among authors: peyrat jp. Eur J Cancer. 1998 May;34(6):791-808. doi: 10.1016/s0959-8049(97)10157-5. Eur J Cancer. 1998. PMID: 9797688 Review.

10

Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.

Blanckaert VD, Hebbar M, Louchez MM, Vilain MO, Schelling ME, Peyrat JP. Blanckaert VD, et al. Among authors: peyrat jp. Clin Cancer Res. 1998 Dec;4(12):2939-47. Clin Cancer Res. 1998. PMID: 9865904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters